LivaNova PLC Free Cash Flow Over Time
| LIVN Stock | USD 51.32 0.38 0.74% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LivaNova PLC Performance and LivaNova PLC Correlation. LivaNova |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LivaNova PLC. If investors know LivaNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LivaNova PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 14 | Earnings Share 0.43 | Revenue Per Share 22.907 | Quarterly Revenue Growth 0.112 | Return On Assets 0.0434 |
The market value of LivaNova PLC is measured differently than its book value, which is the value of LivaNova that is recorded on the company's balance sheet. Investors also form their own opinion of LivaNova PLC's value that differs from its market value or its book value, called intrinsic value, which is LivaNova PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LivaNova PLC's market value can be influenced by many factors that don't directly affect LivaNova PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LivaNova PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if LivaNova PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LivaNova PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Free Cash Flow Analysis
Compare LivaNova PLC and related stocks such as Orthopediatrics Corp, Pulmonx Corp, and Si Bone Free Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIDS | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (3.1 M) | (5.9 M) | (13.8 M) | (21 M) | (29.9 M) | (29.8 M) | (29.1 M) | (31.8 M) | (46 M) | (43.7 M) |
| LUNG | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (21.5 M) | (31.5 M) | (45.1 M) | (46.4 M) | (38.4 M) | (40.3 M) |
| SIBN | (14.8 M) | (14.8 M) | (14.8 M) | (1.3 M) | (29.2 M) | (29 M) | (17.2 M) | (18 M) | (15.5 M) | (34.1 M) | (33.2 M) | (45.9 M) | (51.2 M) | (26.5 M) | (27.8 M) |
| NPCE | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (25.5 M) | (21.7 M) | (25 M) | (37.5 M) | (19.9 M) | (20.9 M) |
| GMED | 6.1 M | 53.9 M | 51.8 M | 69.8 M | 54.4 M | 71.2 M | 131 M | 108.2 M | 121.9 M | 101.2 M | 135.1 M | 219.4 M | 104.4 M | 165.2 M | 106.5 M |
| OFIX | 2.6 M | 39 M | (17.6 M) | 37.2 M | 32.4 M | 15.3 M | 26.4 M | 36.4 M | 34.7 M | 11.5 M | 57.2 M | (1.1 M) | (34.7 M) | (107.8 M) | (102.4 M) |
| CNMD | 1.9 M | 81.2 M | 73.7 M | 62.5 M | 49.8 M | 33.1 M | 23.5 M | 52.7 M | 58.2 M | 75.1 M | 51.5 M | 96.9 M | 11.6 M | 106.3 M | 111.6 M |
| ATEC | 683.3 K | 4.5 M | (5.8 M) | (7.3 M) | (31.6 M) | (2.1 M) | (19.1 M) | (16.3 M) | (32.5 M) | (46.2 M) | (70.3 M) | (142 M) | (133.4 M) | (165.5 M) | (157.2 M) |
| GKOS | (21 M) | (21 M) | (21 M) | (14.2 M) | (8 M) | (3.1 M) | 6 M | 19.2 M | 8.5 M | (5.1 M) | (29.9 M) | (23.1 M) | (63.3 M) | (78 M) | (74.1 M) |
| FNA | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (9.7 M) | (24.6 M) | (92.3 M) | (91.9 M) | (87.3 M) |
| ITGR | (30 K) | 67.4 M | 23.8 M | 38.2 M | 56.5 M | (32.1 M) | 46.9 M | 102.1 M | 122.4 M | 117.2 M | 129.9 M | 103.2 M | 41.7 M | 60.3 M | 50.5 M |
| IRTC | (16.2 M) | (16.2 M) | (16.2 M) | (16.2 M) | (16.2 M) | (19.8 M) | (19.4 M) | (18.5 M) | (34.2 M) | (42.3 M) | (27.3 M) | (65.8 M) | (52.8 M) | (90.5 M) | (86 M) |
| BRKR | 1.2 M | 33.3 M | 60.3 M | 94.7 M | 80.5 M | 195 M | 93.7 M | 110.7 M | 190.5 M | 140.4 M | 235 M | 190.4 M | 143 M | 243.2 M | 255.4 M |
LivaNova PLC and related stocks such as Orthopediatrics Corp, Pulmonx Corp, and Si Bone Free Cash Flow description
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.My Equities
My Current Equities and Potential Positions
| LivaNova PLC | LIVN |
Specialization | Health Care, Health Care Equipment & Services |
| Location | United Kingdom |
| Exchange | NASDAQ Exchange |
USD 51.32
Check out LivaNova PLC Performance and LivaNova PLC Correlation. To learn how to invest in LivaNova Stock, please use our How to Invest in LivaNova PLC guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
LivaNova PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.